Macquarie Group LTD Cara Therapeutics, Inc. Transaction History

Macquarie Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$8.24 - $12.56 $4,194 - $6,393	-509 Reduced 34.09%	984 $14,000
Q3 2021 Nov 12, 2021	BUY	$11.55 - $16.06 $11,365 - $15,803	984 Added 193.32%	1,493 $23,000
Q1 2021 May 14, 2021	SELL	$15.07 - $21.71 $3,646 - $5,253	-242 Reduced 32.22%	509 $11,000
Q2 2020 Aug 11, 2020	BUY	$12.39 - $17.33 $9,304 - $13,014	751 New	751 $13,000

102

21.5M

50K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.